| Synonyms: | |
| Status: | Approved (2017) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | K6BUU8J72P |
| InChI Key | MLSQGNCUYAMAHD-ITNVBOSISA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C38H46F4N6O9S |
| Molecular Weight | 838.88 |
| AlogP | 3.86 |
| Hydrogen Bond Acceptor | 11.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 195.22 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 58.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Hepatitis C virus serine protease, NS3/NS4A inhibitor | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
Serine protease S29 regulatory subfamily
|
- | - | - | - | 98 | |
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
|
- | - | - | - | 98 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hepatitis C, Chronic | 4 | D019698 | ClinicalTrials |
| Hepatitis C | 3 | D006526 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Renal Insufficiency, Chronic | 0 | D051436 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1365970-03-1 |
| ChEMBL | CHEMBL3545363 |
| DrugBank | DB13879 |
| DrugCentral | 5243 |
| FDA SRS | K6BUU8J72P |
| Guide to Pharmacology | 11267 |
| PDB | O31 |
| PubChem | 66828839 |
| SureChEMBL | SCHEMBL883097 |
| ZINC | ZINC000164528615 |